Company data
Amneal Pharmaceuticals, Inc. employees and revenue per employee
AMRX · Drug Manufacturers - Specialty & Generic · $7.36B market cap
Amneal Pharmaceuticals, Inc. had 8,500 employees at the end of fiscal Dec 2025, up 4.9% from a year earlier. Revenue for the year was $3.02B, up 8.0% from a year earlier, or $355K per employee. Revenue and headcount both grew, and revenue grew faster.
Employees
8,500
+4.9% YoY
Revenue
$3.02B
+8.0% YoY
Revenue / employee
$355K
Peer median $825K
Rank in industry
16 of 17
Drug Manufacturers - Specialty & Generic
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Dec 2025 | 8,500 | $3.02B | $355K | +4.9% | +8.0% |
| Dec 2024 | 8,100 | $2.79B | $345K | +5.2% | +16.7% |
| Dec 2023 | 7,700 | $2.39B | $311K | +1.3% | +8.2% |
| Dec 2022 | 7,600 | $2.21B | $291K | +8.6% | +5.7% |
| Dec 2021 | 7,000 | $2.09B | $299K | +16.7% | +5.1% |
| Dec 2020 | 6,000 | $1.99B | $332K | +9.1% | +22.5% |
| Dec 2019 | 5,500 | $1.63B | $296K | -8.3% | -2.2% |
| Dec 2018 | 6,000 | $1.66B | $277K | — | +60.9% |
Open roles: we have not matched a verified job board for this company yet.
Amneal Pharmaceuticals, Inc. against similar companies
The closest industry peers by revenue, from Drug Manufacturers - Specialty & Generic.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| COLL Collegium Pharmaceutical, Inc. | 423 | $781M | $1.85M | Efficient growth |
| INDV Indivior Pharmaceuticals Inc | 827 | $1.24B | $1.50M | Leaner |
| LNTH Lantheus Holdings, Inc. | 1,193 | $1.54B | $1.29M | Hiring ahead |
| ANIP ANI Pharmaceuticals, Inc. | 970 | $883M | $911K | Efficient growth |
| EBS Emergent BioSolutions Inc. | 900 | $743M | $825K | Contracting |
| ZTS Zoetis Inc. | 14,500 | $9.47B | $653K | Hiring ahead |
| PAHC Phibro Animal Health Corporation | 2,605 | $1.52B | $583K | Efficient growth |
| ELAN Elanco Animal Health Incorporated | 9,400 | $4.71B | $502K | Efficient growth |
| AMRX Amneal Pharmaceuticals, Inc. | 8,500 | $3.02B | $355K | Efficient growth |
Questions about Amneal Pharmaceuticals, Inc.
- How many employees does Amneal Pharmaceuticals, Inc. have?
- Amneal Pharmaceuticals, Inc. reported 8,500 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 27, 2026. That is up 4.9% from a year earlier.
- What is Amneal Pharmaceuticals, Inc.'s revenue per employee?
- Amneal Pharmaceuticals, Inc. brought in $3.02B of revenue in fiscal Dec 2025, which is $355K per employee. That ranks 16 of 17 companies we track in Drug Manufacturers - Specialty & Generic, where the median is $825K.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Outpick research
This page is the filings. The research is a membership.
On the first and third Friday of each month Outpick publishes one stock pick with the full case for owning it, adds it to a live portfolio you can audit, and writes a note when a position closes. A new account gets 21 days of the whole membership with no card, and nothing is charged when it ends.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare AMRX with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Amneal Pharmaceuticals, Inc.'s annual reports (Form 10-K), latest filed February 27, 2026. This is data, not a recommendation to buy or sell AMRX.